Assessment of Quantiferon®-CMV and Immuknow® Assays in CMV-seropositive Lung Transplant Recipients to Stratify Risk of CMV Infection
Arch. bronconeumol. (Ed. impr.)
; 58(8): 614-617, Ag. 2022. graf, tab
Article
in English
| IBECS
| ID: ibc-207056
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
ABSTRACT
No disponible
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Lung Transplantation
/
Cytomegalovirus Infections
/
Anti-Bacterial Agents
Limits:
Adult
/
Aged
/
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Arch. bronconeumol. (Ed. impr.)
Year:
2022
Document type:
Article
Institution/Affiliation country:
Hospital Universitari Vall dHebron/Spain
/
Hospital Universitario 12 de Octubre/Spain
/
Hospital Universitario Marqués de Valdecilla/Spain
/
Hospital Universitario Puerta de Hierro/Spain
/
Hospital Universitario Reina Sofía/Spain
/
Hospital Universitario y Politécnico la Fe/Spain
/
Instituto de Investigación Sanitaria Puerta de Hierro/Spain
/
Área Sanitaria de A Coruña y CEE/Spain